APVO Aptevo Therapeutics Inc.

Fundamentals / CIK 0001671584 / USD

Aptevo Therapeutics Inc. reported $13.36M in total assets and a net loss of $25.41M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open APVO in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$43.83M$21.91M$0-$107.9MFY 2016 Revenue: $9.98MFY 2016 Net Income: -$112.4M2016FY 2017 Revenue: $14.66MFY 2017 Net Income: $6.97M2017FY 2018 Revenue: $23.07MFY 2018 Net Income: -$53.69M2018FY 2019 Revenue: $32.42MFY 2019 Net Income: -$40.45M2019FY 2020 Revenue: $4.31MFY 2020 Net Income: -$17.75M2020FY 2021 Revenue: $12.29MFY 2021 Net Income: -$28.46M2021FY 2022 Revenue: $3.11MFY 2022 Net Income: $8.03M2022FY 2023 Net Income: -$17.41M2023FY 2024 Net Income: -$24.13M2024FY 2025 Net Income: -$25.97M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- -- -- $3.11M $12.29M $4.31M $32.42M $23.07M $14.66M $9.98M
Cost of Revenue -- -- -- -- -- -- $19.93M $11.21M $5.01M $12.47M
Gross Profit -- -- -- -- -- -- $12.50M $11.85M $9.65M -$2.48M
Research & Development $14.54M $14.38M $17.11M $17.88M $18.99M $17.85M $24.76M $35.38M $29.02M $29.12M
Selling, General & Admin -- -- -- -- -- -- $25.34M $28.13M $34.58M $36.16M
Operating Income -$26.31M -$24.60M -$28.88M -$28.64M -$21.40M -$27.49M -$40.96M -$51.66M -$53.95M -$138.8M
EBITDA -$26.07M -$24.25M -$28.31M -$27.74M -$20.26M -$26.09M -$38.73M -$49.27M -$50.82M -$135.4M
Income Before Tax -$25.97M -$24.13M -$18.65M $7.01M -$29.41M -$30.92M -$43.06M -$53.69M -$55.89M -$139.6M
Income Tax Expense $0 -- -- -- -- -- -- -- -$23.30M -$19.69M
Net Income -$25.97M -$24.13M -$17.41M $8.03M -$28.46M -$17.75M -$40.45M -$53.69M $6.97M -$112.4M
Basic EPS -$78,480.22 -$28,291,573.74 -$6,561,729,074,790,055.00 $544,120,917,006,581,760,000.00 -$2,103,703,163,203,790,569,472.00 -$1,812,581,143,913,645,211,648.00 -$4,803,513,318,287,403,384,832.00 -$11,666,358,586,576,927,195,136.00 $1,610,836,122,832,797,696,000.00 -$27,091,334,793,097,048,489,984.00
Diluted EPS -$78,480.22 -$28,291,573.74 -$6,561,729,074,790,055.00 $544,120,917,006,581,760,000.00 -$2,103,703,163,203,790,569,472.00 -$1,812,581,143,913,645,211,648.00 -$4,803,513,318,287,403,384,832.00 -$11,666,358,586,576,927,195,136.00 $1,610,836,122,832,797,696,000.00 -$27,091,334,793,097,048,489,984.00
Basic Shares Outstanding 351 1 0 0 0 0 0 0 0 0
Diluted Shares Outstanding 351 1 0 0 0 0 0 0 0 0

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $3.74M $3.70M $3.92M $3.54M $4.04M $3.33M $3.63M $3.88M
Operating Income -$6.61M -$6.44M -$6.84M -$6.00M -$7.61M -$6.23M -$6.48M -$6.38M
EBITDA -$6.58M -$6.41M -$6.80M -$5.92M -$7.56M -$6.18M -$6.42M -$6.31M
Net Income -$6.55M -$6.36M -$6.70M -$5.81M -$7.55M -$6.20M -$6.41M -$6.31M
Basic EPS -$5.19 -$5.31 -$5,764.39 -- -$40.13 -$151.29 -$1,422,491.01 --
Diluted EPS -$5.19 -$5.31 -$5,764.39 -- -$40.13 -$151.29 -$1,422,491.01 --
Basic Shares Outstanding 1.8M 1.2M 1.2K -- 224.9K 41.0K 5 --
Diluted Shares Outstanding 1.8M 1.2M 1.2K -- 224.9K 41.0K 5 --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $21.62M $8.71M $16.90M $22.64M $45.04M $39.98M $12.45M $30.64M $7.09M $9.68M
Short-Term Investments -- -- -- -- -- -- -- -- $73.69M $44.85M
Cash & Short-Term Investments $21.62M $8.71M $16.90M $22.64M $45.04M $39.98M $12.45M $30.64M $80.78M $54.52M
Accounts Receivable, Net -- -- -- -- -- -- $7.02M $5.22M $2.14M $307K
Inventory -- -- -- -- -- -- $6.14M $1.78M $1.03M $461K
Other Current Assets $853K $1.02M $689K $744K $780K $133K $160K $4.14M $6.71M $2.03M
Total Current Assets $23.08M $10.66M $19.07M $27.45M $52.57M $47.26M $30.00M $48.69M $95.08M $71.41M
Property, Plant & Equipment, Net $303K $543K $895K $1.46M $2.38M $2.81M $3.95M $5.20M $5.84M $5.91M
Intangible Assets -- -- -- -- -- -- $4.42M $5.25M $6.08M $6.91M
Other Non-Current Assets -- -- -- -- $68K $746K $757K $905K -- --
Total Non-Current Assets $4.11M $4.93M $5.78M $6.76M $4.03M $6.28M $23.41M $18.80M $21.92M $20.44M
Total Assets $27.19M $15.59M $24.84M $34.22M $56.60M $53.55M $53.41M $67.49M $117.0M $91.86M
Accounts Payable $877K $1.24M -- -- -- -- $6.43M $11.67M -- --
Short-Term Debt -- -- -- $2.00M $11.67M $5.00M $19.86M -- $3.33M --
Deferred Revenue (Current) -- -- -- -- -- -- -- -- -- $811K
Other Current Liabilities -- $1.30M $1.14M $1.10M $2.09M $1.20M $944K $796K $2.58M $278K
Total Current Liabilities $6.05M $6.21M $7.22M $8.71M $34.76M $14.54M $38.24M $17.61M $18.51M $19.54M
Long-Term Debt -- -- $0 $1.46M $3.71M $23.22M -- $19.28M $15.73M $18.38M
Deferred Revenue (Non-Current) -- -- -- -- -- -- -- -- -- $2.90M
Other Non-Current Liabilities -- $0 -- -- -- -- -- $200K $734K $469K
Total Non-Current Liabilities $3.76M $4.63M $5.40M $7.54M $20.63M $22.41M $3.33M $19.48M $16.46M $21.75M
Total Liabilities $9.81M $10.84M $12.62M $16.24M $55.38M $36.95M $41.57M $37.09M $34.97M $41.29M
Total Debt (incl. Leases) $4.63M $5.40M $6.08M $9.92M $17.71M $30.58M $24.12M $19.28M $19.06M $18.38M
Common Stock $114K $84K $61K $48K $47K $46K $45K $23K $22K $20K
Retained Earnings -$275.1M -$247.6M -$223.4M -$206.0M -$214.1M -$185.6M -$167.9M -$127.4M -$73.72M -$80.69M
Accumulated Other Comp. Income -- -- -- -- -- -- -- -- -$105K -$33K
Total Stockholders' Equity $17.38M $4.75M $12.22M $17.97M $1.22M $16.59M $11.84M $30.41M $82.03M $50.57M
Total Equity $17.38M $4.75M $12.22M $17.97M $1.22M $16.59M $11.84M $30.41M $82.03M $50.57M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $8.27M $9.80M $14.53M $21.62M $9.41M $9.41M $2.14M $8.71M
Cash & Short-Term Investments $8.27M $9.80M $14.53M $21.62M $9.41M $9.41M $2.14M $8.71M
Other Current Assets $967K $462K $851K $853K $77K $82K $120K $1.02M
Total Current Assets $9.70M $10.80M $15.98M $23.08M $22.65M $11.08M $3.61M $10.66M
Property, Plant & Equipment, Net $353K $236K $268K $303K $384K $432K $482K $543K
Total Non-Current Assets $3.67M $3.72M $3.92M $4.11M $4.35M $4.54M $4.74M $4.93M
Total Assets $13.36M $14.52M $19.90M $27.19M $27.00M $15.62M $8.34M $15.59M
Accounts Payable $1.48M $1.16M $890K $877K -- -- -- $1.24M
Other Current Liabilities -- -- -- -- $1.49M $948K $1.13M $1.30M
Total Current Liabilities $6.46M $5.19M $4.76M $6.05M $5.61M $4.89M $5.39M $6.21M
Other Non-Current Liabilities -- -- -- -- -- -- -- $0
Total Non-Current Liabilities $3.04M $3.29M $3.53M $3.76M $3.99M $4.21M $4.42M $4.63M
Total Liabilities $9.50M $8.48M $8.29M $9.81M $9.60M $9.10M $9.81M $10.84M
Total Debt (incl. Leases) $3.99M $4.21M $4.42M $4.63M $4.80M $5.00M $5.20M $5.40M
Common Stock $115K $114K $114K $114K $110K $99K $84K $84K
Retained Earnings -$297.6M -$288.3M -$281.9M -$275.1M -$269.2M -$260.2M -$254.0M -$247.6M
Total Stockholders' Equity $3.86M $6.04M $11.61M $17.38M $17.39M $6.52M -$1.47M $4.75M
Total Equity $3.86M $6.04M $11.61M $17.38M $17.39M $6.52M -$1.47M $4.75M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$25.97M -$24.13M -$17.41M $8.03M -$28.46M -$17.75M -$40.45M -$53.69M $6.97M -$112.4M
Depreciation & Amortization $240K $352K $567K $901K $1.14M $1.41M $2.23M $2.39M $3.13M $3.36M
Stock-Based Compensation $96K $1.07M $2.19M $1.80M $1.64M $1.25M $1.60M $2.14M $4.88M $3.81M
Change in Receivables -- -- -- -- -- -- -$1.80M -$3.08M -$1.83M $2.17M
Change in Inventory -- -- -- -- -- -- -$4.35M -$757K -$567K $13.68M
Operating Cash Flow -$25.59M -$23.79M -$11.73M -$21.02M -$21.68M -$29.32M -$42.38M -$51.42M -$41.57M -$36.86M
Capital Expenditure -- -- -- -$29K -$713K -$88K -$153K -$976K -$1.40M -$2.51M
Free Cash Flow -- -- -- -$21.05M -$22.39M -$29.41M -$42.54M -$52.40M -$42.98M -$39.37M
Purchases of Investments -- -- -- -- -- -- -- -$16.54M -$99.63M -$44.88M
Sales & Maturities of Investments -- -- -- -- -- -- -- $90.24M $70.73M --
Investing Cash Flow $0 $0 $0 -$29K -$713K $28.03M $4.10M $72.80M $29.46M -$47.39M
Common Stock Issued $37.94M $10.04M $6.43M $6.93M $10.23M -- -- $623K $442K --
Financing Cash Flow $38.50M $15.60M $6.00M -$2.62M $26.16M $23.87M $20.15M -$787K $19.53M $89.30M
Net Change in Cash $12.90M -$8.19M -$5.73M -$23.67M $3.77M $22.59M -$18.14M $20.59M $7.42M $5.04M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$6.55M -$6.36M -$6.70M -$5.81M -$7.55M -$6.20M -$6.41M -$6.31M
Depreciation & Amortization $39K $32K $35K $81K $49K $49K $61K $71K
Stock-Based Compensation $51K $58K $57K $2.0K $77K -$163K $180K -$72K
Change in Payables $315K $272K $13K -- $267K -$936K $278K --
Operating Cash Flow -$5.69M -$5.45M -$7.96M -$5.24M -$6.69M -$7.09M -$6.58M -$5.76M
Investing Cash Flow -$156K $0 $0 $0 $0 $0 $0 --
Common Stock Issued $4.32M $726K $872K $5.24M $18.34M $14.36M $0 --
Financing Cash Flow $4.32M $726K $871K $5.79M $18.34M $14.36M $0 $6.72M
Net Change in Cash -$1.53M -$4.73M -$7.09M $558K $11.65M $7.27M -$6.58M $961K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin -- -- -- -- -- -- 38.5% 51.4% 65.8% -24.9%
Operating Margin -- -- -- -919.7% -174.1% -638.1% -126.3% -224.0% -368.1% -1389.8%
Net Profit Margin -- -- -- 257.8% -231.5% -411.9% -124.7% -232.8% 47.6% -1125.8%
Return on Equity (ROE) -149.4% -507.5% -142.5% 44.7% -2340.2% -107.0% -341.6% -176.6% 8.5% -222.3%
Return on Assets (ROA) -95.5% -154.8% -70.1% 23.5% -50.3% -33.1% -75.7% -79.5% 6.0% -122.4%
Current Ratio 3.82x 1.72x 2.64x 3.15x 1.51x 3.25x 0.78x 2.76x 5.14x 3.65x
Quick Ratio 3.57x 1.40x 2.34x 2.60x 1.30x 2.75x 0.62x 2.66x 5.08x 3.63x
Debt to Equity 0.27x 1.14x 0.50x 0.55x 14.57x 1.84x 2.04x 0.63x 0.23x 0.36x
Revenue Growth (YoY) -- -- -- -74.7% +185.3% -86.7% +40.6% +57.4% +46.8% -70.3%
Gross Profit Growth (YoY) -- -- -- -- -- -- +5.4% +22.9% -- -114.9%
Net Income Growth (YoY) -- -- -316.9% -- -- -- -- -870.0% -- --
EPS Growth (YoY) -- -- -100.0% -- -- -- -- -824.2% -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -658.1% -437.1% -226.1% -149.4% -152.2% -368.3% -- -507.5%
Return on Assets (ROA) -190.1% -181.9% -131.9% -95.5% -98.1% -153.8% -284.2% -154.8%
Current Ratio 1.50x 2.08x 3.36x 3.82x 4.03x 2.27x 0.67x 1.72x
Quick Ratio 1.28x 1.89x 3.05x 3.57x 1.68x 1.92x 0.40x 1.40x
Debt to Equity 1.03x 0.70x 0.38x 0.27x 0.28x 0.77x -- 1.14x
Source: SEC EDGAR CompanyFacts (CIK 0001671584) · from March 31, 2015 Data through September 30, 2026 · synced Nov 21, 2026, 05:11 UTC · Open in terminal